Gaowei Nian

机构：Sanofi (China)

发表论文 4 篇 · 总被引 48 次 · h-index 3

代表论文

• Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/ mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the LixiLan‐L‐CN randomized controlled trial (2022 · Diabetes Obesity and Metabolism · 被引 28)
• Efficacy and safety of a single intra-articular injection of 6 ml Hylan G-F 20 compared to placebo in Chinese patients with symptomatic knee osteoarthritis (2021 · BMC Musculoskeletal Disorders · 被引 14)
• Efficacy and safety of rilzabrutinib in patients with moderate-to-severe atopic dermatitis: 16-week results from a proof-of-concept phase II clinical trial (2025 · British Journal of Dermatology · 被引 7)
• A score test of homogeneity in generalized additive models for zero-inflated count data (2014 · K-State Research Exchange (Kansas State University))